We reviewed a large surgical cohort to investigate the clinical manifestations, EEG and neuroimaging findings, and postoperative @entity410 outcome in @entity1 with drug-resistant @entity1315 ( @entity1315 ). All drug-resistant @entity1315 @entity1 , who were investigated for @entity302 surgery at Jefferson @entity302 Center between 1986 and 2015, were identified. Demographic data, @entity410 data, EEG recordings, brain MRI, pathological findings, and postsurgical @entity410 outcome were reviewed. In total, 18 @entity1 (11 males and seven females) were identified. Sixteen @entity1 (88%) had @entity410 , 12 (66%) had focal @entity410 with @entity73 , and 13 (72%) described auras. Among 15 @entity1 who had brain MRI, 14 @entity1 (93%) had @entity75 . Only three of 15 @entity1 (20%) who had interictal scalp EEG recordings showed parietal interictal spikes. Of 12 @entity1 with available ictal surface EEG recordings, only three @entity1 (25%) had parietal ictal EEG onset. After a mean follow-up duration of 8.6 years, 14 @entity1 (77.7%) showed a favourable postoperative @entity410 outcome. In @entity1 with @entity1315 , semiology and EEG may be misleading and brain MRI is the most valuable tool to localize the epileptogenic zone. Postsurgical @entity410 outcome was favourable in our @entity1 with drug-resistant @entity1315 .

Drug-resistant XXXX : clinical manifestations and surgery outcome.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure', 'seizures', 'tonic-clonic seizures'] @entity75 :: ('MESH:D001927', 'Disease') :: ['parietal lobe lesions'] @entity73 :: ('MESH:D003072', 'Disease') :: ['impaired awareness'] @entity1315 :: ('MESH:D004833', 'Disease') :: ['PLE', 'parietal lobe epilepsy'] @entity302 :: ('MESH:D004827', 'Disease') :: ['epilepsy', 'Comprehensive Epilepsy']
@entity1315 :: (MESH:D004833,Disease) :: ['parietal lobe epilepsy']
